Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (13862)	1/29/1998 11:40:00 AM
From: Hippieslayer	Respond to of 32384

I have to agree with you Henry. 11000 patients is a lot of people and if the results were just marginal and the FDA agreed, then i have to say that indeed CORR must be affect if not all, at least some of the bios. Let's hope that LGND has more success with their drug.

To: Henry Niman who wrote (13862)	1/29/1998 12:56:00 PM
From: Proton	Respond to of 32384

Re: Maybe Common Sense, Maybe Sign of a Bottom... In fact he quoted one of the big boys who was long on CORR as saying that he would not invest in Biotechs again. One cannot blame him. The money in biotechnology has been made by investing in the companies that commercialize it (read, "big boy drug companies"). Perhaps his remarks are a sign of capitulation, of the sort one finds at bottoms. Maybe this fellow has just awoken to the reality of investing in biotech issues. I know I'm hearing the alarm clock. :-O I'm not sure that investors (institutional as well as retail) have a solid grasp of this aspect. Welcome to the stock market, Henry. You can get real poor waiting for investors to develop a "solid grasp" of anything. Pý